PRR Share Price

Open 0.04 Change Price %
High 0.04 1 Day 0.00 0.00
Low 0.04 1 Week 0.00 0.00
Close 0.04 1 Month 0.01 33.33
Volume 662817 1 Year -0.01 -20.00
52 Week High 0.05
52 Week Low 0.03
PRR Important Levels
Resistance 2 0.04
Resistance 1 0.04
Pivot 0.04
Support 1 0.04
Support 2 0.04
ASX Australia Most Active Stocks
AGO 0.04 0.00%
AGO 0.04 0.00%
AGO 0.04 0.00%
AYR 0.01 0.00%
AYR 0.01 0.00%
AYR 0.01 0.00%
BUR 0.02 0.00%
BUR 0.02 0.00%
BUR 0.02 0.00%
MLX 0.70 2.94%
More..
ASX Australia Top Gainers Stocks
KSO 0.40 3900.00%
DDT 0.02 100.00%
PMQ 0.03 50.00%
IRM 0.03 50.00%
IRM 0.03 50.00%
IRM 0.03 50.00%
GPP 0.03 50.00%
TDO 0.06 50.00%
PUN 0.04 33.33%
PUN 0.04 33.33%
More..
ASX Australia Top Losers Stocks
APP 0.20 -80.00%
APP 0.20 -80.00%
APP 0.20 -80.00%
APP 0.20 -80.00%
TCQ 0.27 -73.53%
GDY 0.01 -50.00%
RXL 0.01 -50.00%
RXL 0.01 -50.00%
RXL 0.01 -50.00%
GBP 0.02 -33.33%
More..

Prima Biomed Ltd (ASX: PRR)

PRR Technical Analysis 2
As on 17th Jan 2017 PRR Share Price closed @ 0.04 and we RECOMMEND Sell for LONG-TERM with Stoploss of 0.04 & Strong Buy for SHORT-TERM with Stoploss of 0.04 we also expect STOCK to react on Following IMPORTANT LEVELS.
PRR Target for January
1st Target up-side N/A
2nd Target up-side N/A
3rd Target up-side N/A
1st Target down-side N/A
2nd Target down-side N/A
3rd Target down-side N/A
PRR Other Details
Segment EQ
Market Capital 0.00
Sector Healthcare
Industry Biotechnology
Offical website http://www.primabiomed.com.au
PRR Address
PRR
151 Macquarie Street
Level 7
Sydney, NSW 2000
Australia
Phone: 61 2 9276 1224
Fax: 61 2 9276 1284
PRR Latest News
Prima BioMed Ltd (PBMD) Upgraded to Buy at Zacks Investment Research   BBNS   - 14th Jan 17
Prima BioMed Commences Recruitment for Second Cohort of Melanoma Trial   Yahoo Finance   - 12th Jan 17
Prima BioMed Enters New Material Transfer Agreement With CYTLIMIC   Marketwired (press release)   - 05th Jan 17
Mid-Day Market Update: Prima BioMed Climbs Following Positive IMP321 Data ...   Nasdaq   - 29th Dec 16
Prima BioMed Ltd: Operational Update   Marketwired (press release)   - 18th Aug 16
Prima BioMed Ltd (PBMD) Gains as Analyst Sees Over 400% Upside   StreetInsider.com   - 31st Dec 15
Why Prima BioMed Limited skyrocketed 43% today   Motley Fool Australia   - 25th May 15
7 reasons Prima BioMed Limited is too risky   Motley Fool Australia   - 22nd May 15
Prima BioMed Announces Strategic Acquisition of Immutep SA   Marketwired (press release)   - 02nd Oct 14
DOW JONES, A NEWS CORP COMPANY   Wall Street Journal   - 18th Apr 12
Interactive Technical Analysis Chart Prima Biomed Ltd ( PRR ASX Australia )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Prima Biomed Ltd
PRR Business Profile
Prima BioMed Ltd., a biotechnology company, researches, develops, and commercializes licensed medical biotechnology products in Australia. Its lead product includes CVac, a cancer vaccine for patients in remission, which has completed two human clinical trials. The company is also developing oral vaccine against human papilloma virus, a virus associated with development of cervical cancer. Prima BioMed Ltd. is based in Sydney, Australia.